BillionToOne announces groundbreaking new COVID-19 test to unlock 1 million daily tests.

Unique Testing Protocol from Precision Diagnostics Company Unlocks 1 Million Tests Per Day

MENLO PARK, CA (April 7, 2020) - The precision diagnostics company BillionToOne today announced a significant development in the struggle against the COVID-19 pandemic. BillionToOne has developed a highly accurate and cost-effective novel COVID-19 test protocol, unlocking the capacity to perform 1+ million tests per day in the United States alone. Test reagents will be available in 2 weeks, pending the manufacture of the kits and an EUA being awarded by the FDA.

"We've all seen the impact this pandemic has had on every aspect of our daily lives," Dr Oguzhan Atay, the CEO of BillionToOne, said. "From the loss of lives and the damage to the economy to the strain on the healthcare system, this coronavirus has delivered a crippling blow to the country. We're honoured to be on the front line of this fight against the pandemic, and we're certain that this unique technology will help save lives and stop the spread of the virus."

More details at: https://pressat.co.uk/releases/billiontoone-announces-groundbreaking-new-covid-19-test-to-unlock-1-million-daily-tests-2c683c790b06ec500c80345ce6b28e03/